Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Aoxing Pharmaceutical Company, Inc. (AOXG) had Revenue of $32.33M for the most recently reported fiscal year, ending 2016-06-30.

Quarterly Annual

Figures for fiscal year ending 2016-06-30

Income Statement Financials
Revenue	$32.33M
Net Income	$2.06M
Cost of Goods Sold	$7.78M
Gross Profit	$24.55M
Operating Expenses	$26.10M
Operating Income	$6.23M
Non-Operating Income/Expense	$-3.34M
Pre-Tax Income	$2.89M
Normalized Pre-Tax Income	$2.89M
Income after Taxes	$2.24M
Income from Continuous Operations	$2.24M
Consolidated Net Income/Loss	$2.24M
Normalized Income after Taxes	$2.24M
EBIT	$6.23M
EBITDA	$7.25M
Weighted-Average Shares Outstanding (Basic)	73.69M
Weighted-Average Shares Outstanding (Diluted)	75.47M
Earnings per Share (EPS) (Basic)	$0.03
Earnings per Share (EPS) (Diluted)	$0.03
Balance Sheet Financials
Current Assets	$26.87M
Property, Plant, and Equipment	$25.60M
Long-Term Assets	$29.36M
Total Assets	$56.23M
Current Liabilities	$37.82M
Long-Term Debt	--
Long-Term Liabilities	$0.34M
Total Liabilities	$38.16M
Common Equity	$18.08M
Tangible Shareholders Equity	$16.20M
Shareholders Equity	$18.08M
Common Shares Outstanding	76.21M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-0.54M
Cash Flow from Investing Activities	$-0.12M
Cash Flow from Financial Activities	$2.95M
Beginning Cash	$5.37M
End Cash	$6.91M
Increase/Decrease in Cash	$1.54M
Stock-Based Compensation	$0.29M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.71
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	1.41
Gross Margin	75.95%
Operating Margin	19.26%
EBIT Margin	19.26%
EBITDA Margin	22.44%
Pre-Tax Profit Margin	8.93%
Profit Margin	6.38%
Free Cash Flow	$-0.65M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.57
Inventory Turnover	2.74
Receiveable Turnover	2.89
Days Sales in Receivables	126.45
Return on Equity	12.41%
Return on Tangible Equity	13.85%
Return on Assets	3.99%
Return on Investments	12.41%
Book Value Per Share	$0.24
Free Cash Flow per Share	$-0.01
Operating Cash Flow per Share	$-0.01

Data from Zacks Investment Research, Inc.